Diagnosis of invasive fungal infections: Advances in nonculture systems

Current Clinical Topics in Infectious Diseases

Volumn , Issue 18, 1998, Pages 101-153

  Walsh, Thomas J ^a   Chanock, Stephen J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FUNGAL DNA; FUNGUS ANTIGEN;

ASCOMYCETES; ASPERGILLOSIS; BLOOD; CANDIDA; CANDIDIASIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; FUNGEMIA; FUSARIUM; GROWTH, DEVELOPMENT AND AGING; HISTOPLASMOSIS; HUMAN; IMMUNOASSAY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUCORMYCOSIS; MYCOSIS; POLYMERASE CHAIN REACTION; REVIEW; TRICHOSPORON;

ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLOSIS; CANDIDA; CANDIDIASIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; DNA, FUNGAL; FUNGEMIA; FUSARIUM; HISTOPLASMOSIS; HUMANS; IMMUNOASSAY; MICROBIAL SENSITIVITY TESTS; MYCOSES; POLYMERASE CHAIN REACTION; PSEUDALLESCHERIA; TRICHOSPORON; ZYGOMYCOSIS;

EID: 0031602654     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (277)

1. Wey SB, Motomi M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148: 2642-2645.
2. Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol 1991: 77-84.
3. Armstrong D. Problems in management of opportunistic fungal diseases. Rev Infect Dis 1989;2(Suppl 7):S1591-S1599.
4. Bodey GP. Candidiasis in cancer patients. Am J Med 1984;77(Suppl):13-19.
5. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985;7:646-655.
6. Komshian SV, Uwaydah AK, Sobel JD, Croue LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-390.
7. Lecciones JA, Lee JW, Navarro E, Witebsky FG, Marshall DJ, Steinberg SM, Pizzo PA, Walsh TJ. Vascular catheter-associated fungemia in cancer patients: analysis of 155 episodes. Rev Infect Dis 1992;14:875-883.
8. Maksymiuk AW, Thongprasert S, Hopfer R, et al. Systemic candidiasis in cancer patients. Am J Med 1984;77(Suppl):20-27.
9. Walsh TJ, Pizzo PA. Nosocomial fungal infections. Ann Rev Microbiol 1988;42:517-546.
10. Arena FP, Perlin M, Brahman H, Weiser B, Armstrong D. Fever, rash and myalgias of disseminated candidiasis during antifungal therapy. Arch Intern Med 1981;141:1233-1237.
11. Bodey GP, Luna M. Skin lesions associated with disseminated candidiasis. JAMA 1974; 229:1466-1468.
12. Edwards JE. Candida endophthalmitis. In: Bodey GP, Fainstein V, eds. Candidasis. New York: Raven Press, 1985:211-225.
13. Jarowski CI, Fialk MA, Murray HW, Gottlieb GJ, Coleman M, Steinberg CR, Silver RT. Fever, rash and muscle tenderness. Arch Intern Med 1978;138:544-546.
14. Pizzo PA, Robichaud KJ, Wesley R, Commers J. Fever in the pediatric and young adult patient with cancer: a prospective study of 1001 episodes. Medicine 1982;61:153-165.
15. Solomon SL, Khabbaz RF, Parker RH, Anderson RL, Geraghty MA, Furman RM, Martone WJ. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis 1984;149:98-102.
16. Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988;108: 88-100.
17. Navarro EE, Almario JS, King C, Bacher J, Pizzo PA, Walsh TJ. Candida casts in experimental renal candidiasis in rabbits: implications for diagnosis and pathogenesis of upper urinary tract infection. J Med Vet Mycol 1994;2:415-426.
18. Goldberg PK, Kozinn PJ, Wise J, Nouri N, Brooks RB. Incidence and significance of candiduria. JAMA 1979;241:582-584.
19. Navarro E, Almario JS, Schaufele RL, Bacher J, Walsh TJ. Quantitative urine cultures do not reliably detect renal candidiasis. J Clin Microbiol 1997;35:3292-3297.
20. Merz WG, Roberts GD. Detection and recover of fungi from clinical specimens. In: Murray P, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. American Society for Microbiology, 1995:709-722.
21. Walsh TJ, McEntee C, Dixon DM. Tissue homogenization for quantitative cultures of Candida albicans using sterile reinforced polyethylene bags. J Clin Microbiol 1987; 25:931-932.
22. Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987;9:1006-1012.
23. Walsh TJ, Salkin IF, Dixon DM, Hurd NJ. Clinical microbiological and experimental animal studies of Candida lipolytica. J Clin Microbiol 1989;27:927-931.
24. Merz WG, Khazan U, Jabra-Rizk MA, Wu LC, Osterhout GJ, Lehmann PF. Strain delineation and epidemiology of Candida (Clavispora) lusitaniae. J Clin Microbiol 1992;30:449-454.
25. Wingard JR, Merz WG, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91:539-543.
26. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-1277.
27. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993;37:1847-1849.
28. Murray PR, VanScoy RE, Roberts GD. Should yeasts in respiratory secretions be identified? Mayo Clin Proc 1977;52:42-45.
29. Kwon-Chung J, Bennett JE. Medical mycology. Melvern, PA: Lea & Febiger, 1994.
30. Kreger-van Rij NJW. The yeasts: a taxonomic study. 3rd ed. Amsterdam: Elsevier Science Publishers, 1984.
31. Larone DH. Medically important fungi. A guide to identification. 2nd ed. New York: Elsevier, 1987.
32. McGinnis MR. Yeast identification. Laboratory handbook of medical mycology. New York: Academic Press, 1980:337-410.
33. Rippon JW. Medical mycology: the pathogenic fungi and the pathogenic actinomycetes. 3rd ed. Philadelphia: W.B. Saunders, 1988.
34. Warren NG, Shadomy HJ. Yeasts of medical importance. Manual of clinical microbiology. 5th ed. American Society for Microbiology, 1991:617-629.
35. Slutsky B, Buffo J, Soil DR. High frequency switching of colony morphology in Candida albicans. Science 1985;230:666-669.
36. Yamane N, Saitoh Y. Isolation and detection of multiple yeasts from a single clinical sample by use of Pagano-Levin agar medium. J Clin Microbiol 1985;21:276-277.
37. Allison RT. An evaluation of Pagano-Levin medium in a quantitative study of Candida albicans: preliminary communication. J Med Lab Technol 1967;24:199-202.
38. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32:1923-1929.
39. Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Tomlopsis) glabrata. J Clin Microbiol 1996;34:58-61.
40. Land GA, Harrison BA, Ilulme KL, Cooper BH, Byrd JC. Evaluation of a new API 20C strip for yeasts identification against a conventional method. J Clin Microbiol 1979;10: 357-364.
41. Bowman PI, Ahearn DG. Evaluation of commercial systems for identification of clinical yeast isolates. J Clin Microbiol 1976;4: 49-53.
42. Buesching WJ, Kurek K, Roberts GD. Evaluation of the modified API 20C system.for identification of clinically important yeasts. J Clin Microbiol 1979;9:565-569.
43. Kiehn TE, Edwards FF, Tom D, Lieberman G, Bernard EM, Armstrong D. Evaluation of the Quantum II yeast identification system. J Clin Microbiol 1985;22:216-219.
44. Pfaller MA, Preston T, Bale M, Foontz FP, Body BA. Comparison of the Quantum II, API Yeast Indent, and AutoMicrobic systems for identification of clinical yeast isolates. J Clin Microbiol 1988;26:2054-2058.
45. Cooper BH, Johnson JB, Thaxton ES. Clinical evaluation of the Uni-Yeast-Tek system for rapid presumptive identification of medically important yeasts. J Clin Microbiol 1978;7: 349-355.
46. Oblack DL, Rhodes JC, Martin WJ. Clinical evaluation of the AutoMicrobic System Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol 1981;13:351-355.
47. Sekhon AS, Padhye AA, Gorg AK, Pruitt WR. Evaluation of the Abbott Quantum II yeast identification system. Mykosen 1986;30: 408-411.
48. Hopfer RL, Blan F. Caffeic-acid containing medium for identification of Cryptococcus neoformans. J Clin Microbiol 1975;2:115-120.
49. Kaufmann CS, Merz WG. Two rapid pigmentation tests for identification of Cryptococcus neoformans. J Clin Microbiol 1982; 15:329-331.
50. Rusthoven JJ, Feld R, Tuffnell PJ. Systemic infection by Rhodotorula spp. in the immunocompromised host. J Infect 1984;8:244-246.
51. Pien FD, Thompson RL, Deye D, Roberts GD. Rhodotorula septicemia: two cases and a review of the literature. Mayo Clin Proc 1980;55:258-260.
52. Hopkins JM, Land GA. Rapid methods for determining nitrate utilization by yeasts. J Clin Microbiol 1977;5:497-500.
53. Pore RS. Prototheca taxonomy. Mycopathologia 1985;90:129-139.
54. Danker WM, Spector SA, Fierer J, Davis CE. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis 1987;9:743-753.
55. Gueho E, Simmons RB, Pruitt WR, Meyer SA, Ahearn DG. Association of Malassezia pachydermatis with systemic infections of humans. J Clin Microbiol 1987;25:1789-1790.
56. Richet HM, McNeil MM, Edwards MC, Jarvis WR. Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit. J Clin Microbiol 1989; 27:1197-1200.
57. Kozinn PJ, Taschdjian CL. Candida albicans: saprophyte or pathogen? A diagnostic guideline. JAMA 1966;198:170-172.
58. Odds FC. Candida and candidosis. Philadelphia: Bailliere Tindall, 1988:206-234.
59. Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 1989;149: 2226-2228.
60. Edwards JE Jr, Bodey GP, Bowden RA, Buchner T, de Pauw BE, Filler SG, Ghannoum MA, Glauser M, Herbrecht R, Kauffman CA, Kohno S, Martino P, Meunier F, Mori T, Pfaller MA, Rex JH, Rogers TR, Rubin RH, Solomkin J, Viscoli C, Walsh TJ, White M. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997;25: 43-59.
61. Rex JH, Bennett JE, Sugar AM, Pappas PG, Serody J, Edwards JE, Washburn RG. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 1995;21: 994-996.
62. Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum AM, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997;24:235-247.
63. Walsh TJ, Bustamante C, Vlahov D, Standiford HC. Candida suppurative peripheral thrombophlebitis: prevention, recognition and management. Infect Control 1986;7: 16-22.
64. Braunstein H, Tomaasulo M. A quantitative study of the growth of Candida albicans in vented and unvented blood-culture bottles. Am J Clin Pathol 1976;66:87-90.
65. Gantz NM, Medeiros AA, Swain JL, O'Brien TF. Vacuum blood-culture bottles inhibiting growth of Candida and fostering growth of Bacteroides. Lancet 1974;2: 1174-1176.
66. Roberts GD, Washington JA. Detection of fungi in blood cultures. J Clin Microbiol 1975;1:309-310.
67. Roberts GD, Horstmeier C, Hall M, Washington JA II. Recovery of yeast from vented blood culture bottles. J Clin Microbiol 1975;2:18-20.
68. Hopfer RL, Orengo A, Chesnut S, Wenglar M. Radiometric detection of yeasts in blood cultures of cancer patients. J Clin Microbiol 1980;12:329-331.
69. Kiehn TE, Capitolo C, Mayo JB, Armstrong D. Comparative recovery of fungi from biphasic and conventional blood culture media. J Clin Microbiol 1981;14:681-683.
70. Prevost E, Bannister E. Detection of yeast septicemia by biphasic and radiometric methods. J Clin Microbiol 1981;13:655-660.
71. Murray PR. Comparisons of lysis centrifugation and agitated biphasic blood culture systems for detection of fungemia. J Clin Microbiol 1991;29:96-98.
72. Weckbach LS, Stasneck JL. Performance characteristics of a commercially prepared biphasic blood culture bottle. J Clin Microbiol 1986;23:700-703.
73. Jungkind D, Millan J, Allen S, Dyke J, Hill E. Clinical comparison of a new automated infrared blood culture system with the BACTEC 460 system. J Clin Microbiol 1986; 23:262-266.
74. Komorowski RA, Farmer SG. Rapid detection of candidemia. Am J Clin Pathol 1973; 59:56-61.
75. Dorn GL, Land GA, Wilson GE. Improved blood culture technique based on centrifugation: clinical evaluation. J Clin Microbiol 1979;9:391-396.
76. Henry NK, McLimans CA, Wright AJ, Thompson RL, Wilson WR, Washington JA II. Microbiological and clinical evaluation of the isolator lysis centrifugation blood culture tube. J Clin Microbiol 1983;17:864-869.
77. Bille J, Edson R, Roberts G. Clinical evaluation of the lysis centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system. J Clin Microbiol 1984;19:126-128.
78. Bille J, Stockman L, Roberts GD, Horstmeier CD, Ilstrup DM. Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood. J Clin Microbiol 1983;18:469-471.
79. Buck GE, Hanes V, Kelly MT, Alexander JA. Clinical comparison of the Roche Septi-Chek and Dupont Isolator blood culture systems. Am J Clin Pathol 1987;87:396-398.
80. Guerra-Romero L, Edson RS, Cockerill FR III, Horstmeier CD, Roberts GD. Comparison of DuPont Isolator and Roche Septi-chek for detection of fungemia. J Clin Microbiol 1987;25:1623-1625.
81. Kiehn TE, Wong B, Edward FF, Armstrong D. Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol 1983;18:300-304.
82. Brannon P, Kiehn TE. Large scale clinical comparison of lysis centrifugation and radiometric systems for blood culture. J Clin Microbiol 1986;24:886-887.
83. Kelly MT, Roberts FJ, Henry D, Gccre I, Smith JA. Clinical comparison of isolator and BACTEC 660 resin media for blood culture. J Clin Microbiol 1990;28:1925-1927.
84. Masterson KC, McGowan JE. Detection of positive blood cultures by the BACTEC NR660. The clinical importance of five versus seven days of testing. Am J Clin Pathol 1988;90:91-94.
85. Mirrett S, Davis T, Wilson M, Reynolds J, Fuller D, Koontz F, Allen S, Relier B. Controlled evaluation of BACTEC selective fungal medium for detection of fungemia. Abstr Amer Soc Microbiol C-351:400.
86. Morita T, Tanaka S, Nakamura T, Iwanaga S. A new 1,3-β-D-glucan-mediated coagulation pathway found in Limulus amebocyte. FEBS Lett 1981;129:318-321.
87. Alpert NL. Microbial detection system. Clinical Instrument Systems 1990;11:1-5.
88. Wilson ML, Weinstein MP, Reimer LG, Mirrett S, Relier LB. Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol 1992;30:323-329.
89. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissueproven invasive candidiasis: disseminated versus single organ infection. Diagnostic Microbiol Infect Dis 1993;17:103-109.
90. Haslett TM, Isenberg HD, Tucci V, Kay BG, Vellozzi EM. Microbiology of in-dwelling central intravascular catheters. J Clin Microbiol 1988;26:696-701.
91. Linares J, Stiges-Serra A, Garan J, Perez JL, Martin R. Pathogenesis of catheter sepsis: a prospective study with qualitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985;21:357-360.
92. Walsh TJ, Gonzalez C, Roilides E, Mueller BU, Ali N, Lewis LL, Whitcomb TO, Marshall DJ, Pizzo PA. Fungemia in HIV-infected children: new epidemiologic patterns, emerging pathogens, and improved antifungal outcome. Clin Infect Dis 1995; 20:900-906.
93. Bousgnoux ME, Hill C, Moissenet D, DeChauvin MF, Bonnay M, Vicens-Sprauel I, Pietri F, McNeil M, Kaufman L, Dupouy-Camet J, Bohuon C, Andremont A. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin Microbiol 1990;28:905-909.
94. Lemieux C, St. Germain G, Vincelette J, Kaufman L, DeRepentigny L. Collaborative evaluation of antigen detection by a commercial latex agglutination test and enzyme immunoassay in the diagnosis of invasive candidiasis. J Clin Microbiol 1990;28:249-253.
95. Gold JWM, Wong B, Bernard EM, Kiehn TE, Armstrong D. Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive candidiasis. J Infect Dis 1983;147: 504-513.
96. Wong B, Bernard EM, Armstrong D, Roboz J, Suzuki R, Holland JF. (Letter). J Clin Microbiol 1985;21:478-479.
97. Araj GF, Hopfer RL, Chesnut S, Fainstein V, Bodey GP. Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patients. J Clin Microbiol 1982;16:46-52.
98. Greenfield RA, Jones JM. Purification and characterization of a major cytoplasmic antigen of Candida albicans. Infect Immun 1981;34:469-477.
99. Greenfield RA, Bussey MJ, Stephens JL, Jones JM. Serial enzyme-linked immunosorbent assays for antibody to Candida antigens during induction chemotherapy for acute leukemia. J Infect Dis 1983;148:275-283.
100. Jones JM. Kinetics of antibody responses to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans. J Lab Clin Med 1980;96:845-860.
101. Jones JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990;3: 32-45.
102. Matthews RC, Burnie JP, Tabaqchali S. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol 1987;25: 230-237.
103. Matthews RC, Burnie JP. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47 kD antigen. J Clin Microbiol 1988;26:459-463.
104. Strockbine NA, Largen MT, Buckley HR. Production and characterization of three monoclonal antibodies to Candida albicans proteins. Infect Immun 1984;43:1012-1018.
105. Strockbine NA, Largen MT, Zweibel SM, Buckley HR. Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infect Immun 1984;43:715-721.
106. Taschdjian CL, Kozinn PJ, Cuesta MV, Toni EF. Serodiagnosis of candidal infections. Am J Clin Pathol 1971;57:195-205.
107. Taschdjian CL, Seelig MS, Kozinn PJ. Serological diagnosis of candidal infections. CRC Crit Rev Lab Sci 1973;4:19-59.
108. Mason AB, Brandt ME, Buckley HR. Enolase activity associated with a Candida albicans cytoplasmic antigen. Yeast 1988;5: S231-S240.
109. Bennett JE. Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis 1987;9: 398-401.
110. de Repentigny L. Serodiagnosis of candidiasis, aspergillosis, and cryptococcosis. Clin Infect Dis 1992;14(Suppl 1):S11-S22.
111. Harding SA, Sanford GR, Merz WG. Three serologic tests for candidiasis: diagnostic value in distinguishing deep or disseminated infection from superficial infection or colonization. Am J Clin Pathol 1976;65:1001-1009.
112. Kozinn PJ, Taschdjian CL, Goldberg PK, Protzmann WP, MacKenzie DWR, Remington JD, Anderson S, Seelig MS. Efficiency of serologic tests in the diagnosis of systemic candidiasis. Am J Clin Pathol 1978; 70:893-898.
113. Kozinn PJ, Taschdjian CL, Goldberg PK, Wise GJ, Toni EF, Seelig MS. Advances in the diagnosis of renal candidiasis. J Urol 1978;119:184-187.
114. Meckstroth KL, Reiss E, Keller JW, Kaufman L. Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay. J Infect Dis 1981;144:24-32.
115. Reiss E, Morrison CJ. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev 1993;6:311-323.
116. De Bernardis F, Girmenia C, Boccanera M, Adriani D, Martino P, Cassone A. Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis. J Clin Microbiol 1993;31:3142-3146.
117. Franklyn KM, Warmington JR, Ott AK, Ashman R. An immunodominant antigen of Candida albicans shows homology to the enzyme enolase. Immunol Cell Biol 1990;68: 173-178.
118. Walsh TJ, Hathorn JW, Sobel JD, Merz WG, Sanchez V, Maret SM, Buckley HR, Pfaller MA, Schaufele R, Silva C, Navarro E, Lecciones J, Chandrasekar P, Lee JW, Pizzo PA. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991;324:1026-1031.
119. Mitsutake K, Takasshige M, Takayoshi T, et al. Enolase antigen, mannan antigen, CandTec antigen, and β-glucan in patients with candidemia. J Clin Microbiol 1996;34: 1918-1921.
120. Gutierrez J, Maroto C, Piedrola G, Martin E, Perez JA. Circulating Candida antigens and antibodies: useful markers of candidemia. J Clin Microbiol 1993;31:2550-2552.
121. Matthews RC, Burnie JP, Tabaqchali S. Immunoblot analysis of the serological response in systemic candidosis. Lancet 1984; ii:1415-1418.
122. Bailey JW, Sada E, Brass C, Bennett JE. Diagnosis of systemic candidiasis by latex agglutination for serum antigen. J Clin Microbiol 1985;21:749-752.
123. Fung JC, Donta ST, Tilton RC. Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease. J Clin Microbiol 1986;24: 542-547.
124. Gentry LO, Wilkinson ID, Lea AS, Price MF. Latex agglutination test for detection of Candida antigen in patients with disseminated disease. Eur J Clin Microbiol 1983; 2:122-128.
125. Kahn FW, Jones JM. Latex agglutination tests for detection of Candida antigens in sera of patients with invasive candidiasis. J Infect Dis 1986;153:579-585.
126. Ness JJ, Vaugh WP, Woods GL. Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients. J Infect Dis 1989;159:495-501.
127. Bernard EM, Christiansen KJ, Tsang SF, Kiehn TE, Armstrong D. Rate of arabinitol production by pathogenic yeast species. J Clin Microbiol 1981:189-194.
128. Bernard EM, Wong B, Armstrong D. Stereoisomeric configuration of arabinitol in invasive candidiasis. J Infect Dis 1985;151: 711-715.
129. Roboz J, Suzuki R, Holland JF. Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis. J Clin Microbiol 1980;12:594-602.
130. Wong B, Bernard EM, Gold JWM, Fong D, Armstrong D. The arabinitol appearance rate in laboratory animals and humans: estimation from the arabinitol/creatinine ratio and relevance to the diagnosis of candidiasis. J Infect Dis 1982;146:353-359.
131. Wong B, Bernard EM, Gold JWM, Fong D, Silber A, Armstrong D. Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection. J Infect Dis 1982;146:346-352.
132. Wong B, Castellanos M. Enantioselective measurement of the Candida metabolite D-arabinitol in human serum using multidimensional gas Chromatography and a new chiral phase. J Chromatography 1989;495: 21-30.
133. de Repentigny L, Man LD, Keller JW, Carter AW, Kuykendall RJ, Kaufman L, Reiss E. Comparison of enzyme immunoassay and gas-liquid Chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J Clin Microbiol 1985;21: 972-979.
134. Quong M, Miyada CG, Switchenko AC, Goodman TC. Identification, purification, and characterization of a D-arabinitol-specific dehydrogenase from Candida tropicalis. Biochem Biophys Res Com 1994;196:1323-1329.
135. Switchenko AC, Miyada CG, Goodman TC, Walsh TJ, Wong B, Becker MJ, Ullman EF. An automated enzymatic method for the measurement of D-arabinitol in human serum. J Clin Microbiol 1994;32:92-97.
136. Walsh TJ, Lee JW, Sien T, Schaufele R, Bacher J, Switchenko AW, Goodman T, Pizzo PA. Serum D-arabinitol measured by automated enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans. J Med Vet Mycol 1994;32:205-215.
137. Soyama K, Ono E. Enzymatic fluorometric method for the determination of serum D-arabinitol in serum by initial rate analysis. Clin Chim Acta 1985;149:149-154.
138. Soyama K, Ono E. Improved procedure for determination of serum D-arabinitol by resazurin-coupled method. Clin Chim Acta 1987;168:259-260.
139. Soyama K, Ono E. Enzymatic and gas-liquid Chromatographic measurement of D-arabinitol compared. Clin Chem 1988;3:432.
140. Walsh TJ, Merz WG, Lee JW, Schaufele R, Sein T, Whitcomb P, Burns W, Wingard J, Switchenko AW, Goodman T, Pizzo PA. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am J Med 1995; 99:164-172.
141. Christensson B, Wiebe T, Pehrson C, Larsson L. Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of D-arabinitol/L-arabinitol ratios in urine. J Clin Microbiol 1997;35:636-640.
142. Lehtonen L, Anttila VJ, Ruutu T, Salonen J, Nikoskelainen J, Eerola E, Ruutu P. Diagnosis of disseminated candidiasis by measurement of urine D-arabinitol/L-arabinitol ratio. J Clin Microbiol 1996;34:2175-2179.
143. Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Arai M, Masuda M, Kawai T. A new chromogenic endotoxin-specific assay using recombined Limulus coagulation enzyme and its clinical applications. Clin Chem Acta 1985;149:55-65.
144. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A. Plasma (1-→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995;345:17-20.
145. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard. NCCLS document M27-P. Villanova, PA: NCCLS, 1992.
146. Mitchell TG, Sandin RL, Bowman BH, Meyer W, Merz WG. Molecular mycology: DNA probes and applications of PCR technology. J Med Vet Mycol 1994;32:3351-3366.
147. Pfaller MA. The use of molecular techniques for epidemiologic typing of Candida species. Curr Top Med Mycol 1992;4:43-63.
148. Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE, Shanley DB, Coleman DC. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microbiol 1996;44:399-408.
149. Heyrn B, Honore N, Truffot-Pernot C, Banerjee A, Schurra C, Jacobs WR Jr, van Embden JD, Grosset JH, Cole ST. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994;344:293-298.
150. Walsh TJ, Hiemenz J, Anaissie E. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Hematol/Oncol Clinic N Amer 1996;10:365-400.
151. Buchman TG, Rossier M, Merz WG, Charache P. Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus specific gene. Surgery 1990;108:338-346.
152. Kan VL. Polymerase chain reaction for the diagnosis of candidemia. J Infect Dis 1993; 168:779-783.
153. Walsh TJ, Francesconi A, Kasai M, Chanock SJ. PCR and single-strand conformational polymorphism for recognition of medically important fungi. J Clin Microbiol 1995;33: 3216-3220.
154. Hendricks DA, Stowe BJ, Hoo BS, Kolberg J, Irvine BD, Neuwald PD, Urdea MS, Perrillo RP. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995;104:537-546.
155. Wolcott M. Advances in nucleic acid-based detection methods. Clin Microbiol Rev 1992; 5:370-382.
156. Ferenczy A, Franco E, Arseneau J, Wright TC, Richart RM. Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol 1996;175:651-656.
157. Holmes AR, Cannon RD, Shepherd MG, Jenkinson HF. Detection of Candida albicans and other yeast in blood by PCR. J Clin Microbiol 1994;32:228-231.
158. Miyakawa Y, Mabuchi T, Fukazawa Y. New method for detection of Candida albicans in human blood by polymerase chain reaction. J Clin Microbiol 1993;31:3344-3347.
159. Burgener-Kairuz P, Zuber JP, Jaunin P, Buchman TG, Bille J, Rossier M. Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (LIAI) gene. fragment. J Clin Microbiol 1994;32:1902-1907.
160. Chryssanthou E, Andersson B, Petrini B, Lofdahl S, Tollemar J. Detection of Candida albicans DNA in serum by polymerase chain reaction. Scan J Infect Dis 1994;26:479-485.
161. Botelho AR, Planta RJ. Specific identification of Candida albicans by hybridization with oligonucleotides derived from ribosomal DNA internal spacers. Yeast 1994; 10:709-717.
162. Haynes KA, Westerneng TJ. Rapid identification of Candida albicans, C. glabrata, C. parapsilosis and C. krusei by species specific PCR of large subunit ribosomal DNA. J Med Microbiol 1996;44:390-396.
163. Williams DW, Wilson MJ, Lewis JH, Potts AJ. Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol 1995;33: 2476-2479.
164. Robert F, Lebreton F, Bougnoux ME, Paugam A, Wassermann D, Schlotterer M, Tourte-Schaefer C, Dupouy-Camet J. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol 1995;33:2366-2371.
165. Jordan JA. PCR identification of four medically important Candida species by using a single primer pair. J Clin Microbiol 1994;32: 2962-2967.
166. van Deenter AJ, Goessens WH, van Belkum A, van Vliet HJ, van Etten EW, Verbrugh HA. Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin Microbiol 1995; 33:625-628.
167. Fujita SI, Lasker B, Lott TJ, Reiss E, Morrison CJ. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol 1995;33:962-967.
168. Burnie JP, Golbang N, Matthews RC. Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis. Eur J Clin Microbiol Infect Dis 1997;16:346-350.
169. Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 1989;64:2030-2034.
170. Lischewski A, Ruhnke M, Tennagen I, Schonian G, Morschlauser J, Hacker J. Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles. J Clin Microbiol 1995;33:769-771.
171. van Belkum A, Mol W, van Saene R, Ball LM, van Velzen D, Quint W. PCR-mediated genotyping of Candida albicans strains from bone marrow transplant patients. Bone Marrow Transplant 1994;13:811-815.
172. van Belkum A, Melchers W, de Pauw BE, Scherer S, Quint W, Meis JF. Genotypic characterization of sequential Candida albicans isolates from fluconazole treated neutropenic patients. J Infect Dis 1994;169:1062-1070.
173. White TJ, Burns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis M, et al. PCR protocols. San Diego: Academic Press, 1990:315-324.
174. Stringer JR. The identity of Pneumocystis carinii: not a single protozoan, but a diverse group of exotic fungi. Infect Agents Dis 1993; 2:109-117.
175. Schonian G, Meusel O, Tietz HJ, Meyer W, Graser Y, Tausch I, Presber W, Mitchell TG. Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses 1993;36:171-179.
176. Lin D, Lehmann PF. Random amplified polymorphic DNA for strain delineation with Candida tropicalis. J Med Vet Mycol 1995;33: 241-246.
177. Bostock A, Khattak MN, Matthew R, Burnie J. Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida albicans. J Gen Microbiol 1993; 139:2179-2184.
178. Werner JA, Gorogh T, Lippert BM, Rudert H. DNA amplification for the in vitro detection of Candida albicans in head and neck squamous cell carcinomas. Eur Arch Otorhinolaryng 1995;252:417-421.
179. Bottone E, Wormser G. Capsule-deficient cryptococci in AIDS. Lancet 1985;2:553.
180. Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cercbrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994;18:789-792.
181. Gonzalez C, Shetty D, Lewis L, Mueller B, Pizzo PA, Walsh TJ. Cryptococcosis in HIV-infected children. Pediatr Infect Dis J 1996; 15:796-800.
182. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Relier L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994;32: 1680-1684.
183. Walsh TJ, Melcher GP, Lee JW, Pizzo PA. Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis, and treatment. Curr Top Med Mycology 1993;5:79-113.
184. Gueho E, Smith MT, de Hoog GS, BillonGrand G, Christen R, Batenburg-van der Vegte WH. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek 1992;61:289-316.
185. Lee JW, Melcher GA, Rinaldi MG, Andrews J, Pizzo PA, Walsh TJ. Patterns of morphologic variation in strains of Trichosporon beigelii. J Clin Microbiol 1990;28:2823-2827.
186. Walsh TJ, Kelly P, Peebles R, Lee JW, Lecciones J, Pizzo PA. Biochemical and physiological variables regulating germination of Trichosporon beigelii. J Med Vet Mycol 1994; 32:123-132.
187. Seeliger HPR, Schroter R. A serological study on the antigenic relationship of the form genus Trichosporon. Sabouraudia 1963; 2:248-263.
188. McManus EJ, Bozdech MJ, Jones JM. Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii. J Infect Dis 1985; 151:1167-1169.
189. McManus EJ, Jones JM. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol 1985;21:681-685.
190. Walsh TJ, Lee JW, Melcher GP, Navarro E, Bacher J, Callender D, Reed KD, Wu T, Lopez-Berestein G, Pizzo PA. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis 1992;166:121-133.
191. Walsh TJ, Newman KA, Moody M, Wharton R, Wade JC. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) 1986;65:268-279.
192. Melcher GP, Reed KD, Rinaldi MG, Lee JW, Pizzo PA, Walsh TJ. Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis. J Clin Microbiol 1991;29:192-196.
193. Lyman CA, Garrett KF, Pizzo PA, Walsh TJ. Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging pathogen. J Infect Dis 1994;70:1557-1565.
194. Kozel TR, Mastroianni RP. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect Immun 1976; 14:62-67.
195. Lyman CA, Dcvi S, Nathanson J, Frasch CE, Pizzo PA, Walsh TJ. Detection and quantification of the glucuronoxylomannanlike polysaccharide antigen from clinical and non-clinical isolates of Trichosporon beigelii: implications for pathogenicity. J Clin Microbiol 1994;33:126-130.
196. Walsh TJ, Mitchell T, Larone DH. Histoplasma, Blastomyces, Coccidioides, and other dimorphic fungi causing systemic mycoses. In: Murray P, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, cds. Manual of clinical microbiology. 6th ed. American Society for Microbiology, 1995:749-764.
197. Paya CV, Roberts GD, Cockerill FR III. Laboratory methods for the diagnosis of disseminated histoplasmosis: clinical importance of the lysis-centrifugation blood culture technique. Mayo Clin Proc 1987;62:480-485.
198. Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum in serum and urine specimens. N Engl J Med 1986; 314:83-88.
199. Durkin MM, Connolly PA, Wheat LJ. Comparison of radioimmunoassay and enzymelinked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol 1997;35:2252-2255.
200. Gomez B, Figueroa JI, Hamilton AJ, Oritz BL, Robeldo MA, Restrepo A, Hay RJ. Development of a novel antigen detection test for histoplasmosis. J Clin Microbiol 1997: 2618-2622.
201. Wheat J, Wheat H, Connolly P, Kleiman M, Supparatpinyo K, Nelson K, Bradsher R, Restrepo A. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997;24:1169-1171.
202. Dolan MJ, Lattuda CP, Melcher GP, Zellmer R, Allendoerfer R, Rinaldi MG. Coccidioides immitis presenting as a mycelial pathogen with empyema and hydropneumothorax. J Med Vet Mycol 1992;30: 249-255.
203. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990;3: 247-268.
204. Sonfleris AJ, Klein BS, Courtney BT, Proctor ME, Jones JM. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents. Clin Infect Dis 1994;19:87-92.
205. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium mameffei infection in southeast Asia. Lancet 1994;344:110-113.
206. Sirisanthana V, Sirisanthana T. Penicillium mameffei infection in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1993;12:1021-1025.
207. Kaufman L, Standard PG. Specific and rapid identification of medically important fungi by exoantigen detection. Ann Rev Microbiol 1987;41:209-225.
208. Hall GS, Pratt-Rippin K, Washington JA. Evaluation of a chemiluminescent probe assay for identification of Histoplasma capsulatum isolates. J Clin Microbiol 1992; 30:3003-3004.
209. Huffnagle KE, Gander RM. Evaluation of Gen-Probe's Histoplasma capsulatum and Cryptococcus neoformans AccuProbes. J Clin Microbiol 1993;31:419-421.
210. Padhye AAG, Smith G, McLaughlin D, Standard PG, Kaufman L. Comparative evaluation of a chemiluminescent DNA probe and an exoantigen test for rapid identification of Histoplasma capsulatum. J Clin Microbiol 1992;30:3108-3111.
211. Walsh TJ, Dixon DM. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis, and treatment. Euro J Epidemiol 1989;5:131-142.
212. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 cases. Rev Infect Dis 1990; 12:1147-1201.
213. Panos R, Barr L, Walsh TJ, et al. Factors associated with fatal hemoptysis in cancer patients. Chest 1988;94:1008-1013.
214. Albelda SM, Talbot GH, Gerson SL, et al. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1984;76:1027.
215. Orr DP, Myerowitz RL, Dubois PJ. Pathoradiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 1978;41:2028.
216. Slavin ML, Knowles GK, Phillips MJ, et al. The air crescent sign of invasive pulmonary aspergillosis in acute leukemia. Thorax 1982;37:554.
217. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest 1987;92: 95-99.
218. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-147.
219. Walsh TJ, Garrett K, Feuerstein E, Girton M, Allende M, Bacher J, Francesconi A, Schaufele R, Pizzo PA. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography: a novel non-invasive method for measuring responses of organism-mediated tissue injury. Antimicrob Agents Chemother 1995; 39:1065-1069.
220. Aisner J, Schimpff SC, Wiernik PH. Treatment of invasive aspergillosis: relationship of early diagnosis and treatment to response. Ann Intern Med 1977;86:539.
221. Barloon TJ, Galvin JR, Mori M, Stanford W, Gingrich RD. Ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms. Chest 1991;99:928-933.
222. Rinaldi MG. Invasive aspergillosis. Rev Infect Dis 1983;5:1061-1069.
223. Aisner J, Murillo J, Schimpff SC, et al. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med 1979;90:4-10.
224. Yu VL, Muder RR, Poorsatttar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results of a three-year prospective study. Am J Med 1986;81: 249-256.
225. Treger TR, Visscher DW, Bartlett MS, et al. Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. J Infect Dis 1985;152:572-578.
226. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86:518-524.
227. Saito II, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 1988;94: 745-749.
228. McCabe RE, Brooks RG, Mark JBD, et al. Open lung biopsy in patients with acute leukemia. Am J Med 1985;78:609-616.
229. Burch PA, Karp JE, Merz WG, et al. Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol 1987;5:1985-1993.
230. Karp JE, Burch PA, Merz WG. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 1988;85:203-206.
231. Tang CM, Cohen J. Diagnosing fungal infections in immunocompromised hosts. J Clin Pathol 1992;45:1-5.
232. Lehmann PF, Reiss E. Invasive aspergillosis: antiserum for circulating antigen produced after immunization with serum from infected rabbits. Infect Immun 1978;20:570-572.
233. Reiss E, Lehmann PF. Galactomannan antigenemia in invasive aspergillosis. Infect Immun 1979;25:357-365.
234. Dupont B, Huber M, Kim SJ, et al. Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients with experimentally infected rabbits'. J Infect Dis 1987; 155:1-9.
235. Verweij PE, Rijs AJ, De Pauw BE, Horrevorts AM, Hoogkamp-Korstanje JA, Meis JF. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing. J Clin Pathol 1995;48:474-476.
236. Francis P, Lee JW, Hoffman A, Peter J, Francesconi A, Bacher J, Shelhamer J, Pizzo P, Walsh TJ. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection. J Infect Dis 1994;169:356-368.
237. Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993;31:2489-2490.
238. Verweij PE, Stynen D, Rijs AJ, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33:1912-1914.
239. Andriole VT. Infections with Aspergillus species. Clin Infect Dis 1993;17(Suppl 2):S481-S486.
240. Patterson TF, George D, Miniter P, Andriole VT. Saperconazole therapy in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother 1992;36:2681-2685.
241. Patterson TF, Miniter P, Patterson JE, Rappeport JM, Andriole VT. Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J Infect Dis 1995;171:1553-1558.
242. Patterson TF, Miniter P, Ryan JL, Andriole VT. Effect of immunosuppression and amphotericin Bon Aspergillus antigenemia in an experimental model. J Infect Dis 1988; 158:415-422.
243. Wong B, Brauer KL, Tsai RR, Jayasimhulu K. Increased amounts of the Aspergillus metabolite D-mannitol in tissue and serum of rats with experimental aspergillosis. J Infect Dis 1989;160:95-103.
244. Tang CM, Holden DW, Aufauvre-Brown A, Cohen J. The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. Am Rev Respir Dis 1993;148:1313-1317.
245. Hopfer RL, Walden P, Setterquist S, Highsmith WE. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J Med Vet Mycol 1993;31:65-75.
246. Einsele H, Hebart H, Roller G, Loffler J, Rothenhofer I, Muller CA, Bowden RA, van Burik J, Engelhard D, Kanz L, Schumacher U. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997;35:1353-1360.
247. Verweij PE, Latge JP, Rijs AJ, Melchers WJ, De Pauw BE, Hoogkamp-Korstanje JA, Meis JF. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid, for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995;33:3150-3153.
248. Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M. PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J Clin Microbiol 1996; 34:2464-2468.
249. Walsh TJ, Francesconi A, Kasai M, Chanock SJ. PCR and single-strand conformational polymorphism for recognition of medically important fungi. J Clin Microbiol 1995;33: 3216-3220.
250. Agger WA, Maki DG. Mucormycosis: a complication of critical care. Arch Intern Med 1978;138:925-931.
251. Cocanour CS, Miller-Crotchett P, Reed RL 2d, Johnson PC, Fischer RP. Mucormycosis in trauma patients. J Trauma 1992;32:12-15.
252. Sugar AM. Mucormycosis. Clin Infect Dis 1992;14(Suppl 1):S126-S129.
253. Walsh TJ, Renshaw G, Andrews J, KwonChung J, Cunnion RC, Pass HI, Taubenberger J, Wilson W, Pizzo PA. Invasive zygomycosis due to Conidiobolus incongruus. Clin Infect Dis 1994;19:423-430.
254. Yousem DM, Galetta SL, Gusnard DA, Goldberg HI. MR findings in rhinocerebral mucormycosis. J Computer Assisted Tomography 1989;13:878-882.
255. Rozich J, Oxendine D, Heffner J, Brzezinski W. Pulmonary zygomycosis. A cause of positive lung scan diagnosed by bronchoalveolar lavage. Chest 1989;95:238-240.
256. Chandler FW, Kaplan W, Ajello L. Color atlas and text of the histopathology of mycotic diseases. Chicago: Year Book, 1980:122-127, 294-301.
257. Chandler FW, Watts JC, Kaplan W, et al. Zygomycosis. Report of four cases with formation of chlamydoconidia in tissue. Am J Clin Pathol 1985;84:9-14.
258. Goodman NL, Rinaldi MG. Agents of zygomycosis. In: Balows A, Hausler WJ, Herrmann K, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. American Society for Microbiology, 1991: 674-692.
259. Anaissie E, Bodey GP, Kantarjian H, Ro J, Vartivarian SE, Hopfer R, Hoy J, Rolston K. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989;11:369-378.
260. Anaissie E, Kantarjian H, Jones P, Barlogie B, Luna M, Lopez-Berestein G, Bodey GP. Fusarium: a newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986;57:2141-2145.
261. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994;Suppl 1:7-15.
262. Merz W, Karp J, Hoagland M, et al. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis 1988;158: 1046-1055.
263. Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine 1988;67: 77-83.
264. Kappe R, Fauser C, Okeke CN, Maiwald M. Universal fungus-specific primer systems and group-specific hybridization oligonucleotides for 18S rDNA. Mycoses 1996;39:25-30.
265. Appel DJ, Gordon TR. Intraspecific variation within populations of Fusarium oxysporum based on RFLP analysis of the intergenic spacer region of the rDNA. Exp Mycol 1995; 19:120-128.
266. Appel DJ, Gordon TR. Relationships among pathogenic and nonpathogenic isolates of Fusarium oxysporum based on the partial sequence of the intergenic spacer region of the ribosomal DNA. Mol Plant Microbe Interact 1996;9:125-138.
267. Bridge PD, Hopkinson LA, Rutherford MA. Rapid mitochondrial probes for analysis of, polymorphisms in Fusarium oxysporum lforms. Lett Appl Microbiol 1995;21: 198-201.
268. Alsip SG, Cobbs CG. Pseudallescheria boydii infection of the central system in a cardiac transplant recipient. South Med J 1986;79: 383-384.
269. Armin AR, Reddy VB, Orfei E. Fungal endocarditis caused by Pseudallescheria (Petriellidium) boydii in an intravenous drug user. Texas Heart Inst J 1987;14:321-324.
270. Berenguer J, Diaz-Mediavilla J, Urra D, Munoz P. Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev Infect Dis 1990;11:890-896.
271. Galgiani JN, Stevens DA, Graybill JR, Stevens DL, Tillinghest AJ, Levine HB. Pseudallescheria boydii infections treated with ketoconazole. Clinical evaluations of seven patients and in vitro susceptibility results. Chest 1984;86:219-224.
272. Travis LB, Roberts GD, Wilson WR. Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. Mayo Clinic Proc 1985;60:531-537.
273. Welty FK, McLeod GX, Ezratty C, Healy RW, Karchmer AW. Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient. Clin Infect Dis 1992; 15:858-860.
274. Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA. Activity of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents Chemother 1995; 39:1361-1364.
275. Wood GM, McCormack JG, Muir DB, Ellis DH, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992;14:1027-1033.
276. Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33:2913-2919.
277. Walsh TJ, Hiemenz J, Pizzo PA. Evolving risk factors for invasive fungal infections - all neutropenic patients are not the same. Clin Infect Dis 1994;18:793-798.